156 related articles for article (PubMed ID: 23679249)
1. Scoring system and management algorithm assessing the role of survivin expression in predicting progressivity of HPV infections in precancerous cervical lesions.
Indarti J; Aziz MF; Suryawati B; Fernando D
Asian Pac J Cancer Prev; 2013; 14(3):1643-7. PubMed ID: 23679249
[TBL] [Abstract][Full Text] [Related]
2. Comparison of p16INK4a immunocytochemistry with the HPV polymerase chain reaction in predicting high grade cervical squamous intraepithelial lesions.
Indarti J; Fernando D
Asian Pac J Cancer Prev; 2013; 14(9):4989-92. PubMed ID: 24175764
[TBL] [Abstract][Full Text] [Related]
3. Survivin and telomerase expression in the uterine cervix of women with human papillomavirus-induced lesions.
Barbosa LC; da Silva ID; Corrêa JC; Ribalta JC
Int J Gynecol Cancer; 2011 Jan; 21(1):15-21. PubMed ID: 21330827
[TBL] [Abstract][Full Text] [Related]
4. Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1-2 lesions.
Li Y; Liu J; Gong L; Sun X; Long W
Virol J; 2019 Oct; 16(1):117. PubMed ID: 31619262
[TBL] [Abstract][Full Text] [Related]
5. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Costa S; Benedetto A; Casolati EA; Favalli C; Paba P; Di Bonito P; Mariani L; Syrjänen S; Bonifacio D; Accardi L; Zanconati F; Syrjänen K;
Am J Clin Pathol; 2005 Jul; 124(1):113-21. PubMed ID: 15923164
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
7. The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
Redman R; Rufforny I; Liu C; Wilkinson EJ; Massoll NA
Arch Pathol Lab Med; 2008 May; 132(5):795-9. PubMed ID: 18466028
[TBL] [Abstract][Full Text] [Related]
8. Endonuclease-resistant DNA: a novel histochemical marker for cervical intraepithelial neoplasia and cervical carcinoma.
Castellanos MR; Davidov A; Punia V; Szerszen A; Maiman M; Lazzaro B; Ahern K; Banerjee P
Int J Gynecol Pathol; 2012 Jan; 31(1):1-7. PubMed ID: 22123717
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
10. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer.
Branca M; Giorgi C; Santini D; Di Bonito L; Ciotti M; Benedetto A; Paba P; Costa S; Bonifacio D; Di Bonito P; Accardi L; Favalli C; Syrjänen K;
J Clin Pathol; 2006 Jan; 59(1):40-7. PubMed ID: 16394279
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.
Branca M; Giorgi C; Ciotti M; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Mariani L; Ruutu M; Syrjänen S; Favalli C; Syrjänen K
Diagn Cytopathol; 2006 Nov; 34(11):739-48. PubMed ID: 17041957
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
[TBL] [Abstract][Full Text] [Related]
14. Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia.
Lee YY; Song SY; Do IG; Kim TJ; Kim BG; Lee JW; Bae DS
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):180-4. PubMed ID: 22959143
[TBL] [Abstract][Full Text] [Related]
15. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
[TBL] [Abstract][Full Text] [Related]
17. Human telomerase gene and high-risk human papillomavirus infection are related to cervical intraepithelial neoplasia.
Zhao XY; Cui Y; Jiang SF; Liu KJ; Han HQ; Liu XS; Li Y
Asian Pac J Cancer Prev; 2015; 16(2):693-7. PubMed ID: 25684510
[TBL] [Abstract][Full Text] [Related]
18. Detection of HPV-induced cervical (pre) neoplastic lesions: a tissue microarray (TMA) study.
Arafa M; Boniver J; Delvenne P
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):422-32. PubMed ID: 18542030
[TBL] [Abstract][Full Text] [Related]
19. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Int J Gynecol Pathol; 2008 Apr; 27(2):265-73. PubMed ID: 18317213
[TBL] [Abstract][Full Text] [Related]
20. Study on the Association between the Fibroblast Growth Factor Receptor 4 Expression and High-Risk Human Papillomavirus Infection in Cervical Cancer and Precancerous Lesions.
Guo L; Zhao A; Zhang R; Xie Y; Xu X
Gynecol Obstet Invest; 2018; 83(6):608-614. PubMed ID: 29982249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]